For patients with advanced or metastatic adrenocortical carcinoma, systemic therapy is the primary treatment. Options include mitotane, chemotherapy, targeted therapies, and immunotherapies. Because the disease is rare and difficult to treat, research is ongoing to identify more effective approaches and improve outcomes.

Mitotane is the most established systemic therapy. It suppresses adrenal hormone production and has direct anti-tumor effects. It is used as monotherapy or in combination with chemotherapy. Chemotherapy regimens, including etoposide, doxorubicin, and cisplatin, are used for advanced disease. Targeted therapies that inhibit specific molecular pathways involved in tumor growth are being studied, and some have shown promise. Immunotherapies, which harness the immune system to fight cancer, are also being investigated. Each approach has benefits and limitations, and treatment selection depends on disease characteristics, prior therapies, and patient factors. These options drive demand for pharmaceuticals and shape the Adrenocortical Carcinoma Treatment Market.

Managing side effects is an important part of care. Mitotane can cause gastrointestinal, neurological, and endocrine side effects, requiring monitoring and dose adjustment. Chemotherapy can cause fatigue, nausea, and bone marrow suppression. Supportive care, including antiemetics, growth factors, and counseling, helps patients tolerate treatment. Because the disease is rare, clinical trials are essential for evaluating new therapies and improving outcomes. Patients are encouraged to discuss trial participation with their healthcare providers. As research progresses, new treatments may offer better disease control and quality of life.

People Also Ask

What systemic therapies are used for adrenocortical carcinoma?
Options include mitotane, chemotherapy regimens such as etoposide, doxorubicin, and cisplatin, targeted therapies, and immunotherapies.

What are the side effects of mitotane?
Mitotane can cause gastrointestinal, neurological, and endocrine side effects, requiring monitoring and dose adjustment.

Tags: #AdrenocorticalCarcinoma #SystemicTherapy #Mitotane #Chemotherapy #Oncology #CancerResearch